Glimepiride: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Glimepiride. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Headache | 8.2% |
| Accidental injury† | 5.8% |
| Flu syndrome | 5.4% |
| Nausea | 5% |
| Dizziness | 5% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Glimepiride tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1) ]. 1.1 Important Limitations of UseGlimepiride tablets USP should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings.
Source: FDA labeling via NIH DailyMed (set 1c6cc8d3…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.